DOI QR코드

DOI QR Code

Cross-cultural adaptation and validation of the Behcet's Disease Current Activity Form in Korea

  • Choi, Hyo Jin (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Seo, Mi Ryoung (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Ryu, Hee Jung (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Baek, Han Joo (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center)
  • Received : 2014.05.21
  • Accepted : 2014.08.29
  • Published : 2015.09.01

Abstract

Background/Aims: This study was undertaken to perform a cross-cultural adaptation of the Behcet's Disease Current Activity Form (BDCAF, version 2006) questionnaire to the Korean language and to evaluate its reliability and validity in a population of Korean patients with Behcet's disease (BD). Methods: A cross-cultural study was conducted among patients with BD who attended our rheumatology clinic between November 2012 and March 2013. There were 11 males and 35 females in the group. The mean age of the participants was 48.5 years and the mean disease duration was 6.4 years. The first BDCAF questionnaire was completed on arrival and the second assessment was performed 20 minutes later by a different physician. The test-retest reliability was analyzed by computing ${\kappa}$ statistics. Kappa scores of > 0.6 indicated a good agreement. To assess the validity, we compared the total BDCAF score with the patient's/clinician's perception of disease activity and the Korean version of the Behcet's Disease Quality of Life (BDQOL). Results: For the test-retest reliability, good agreements were achieved on items such as headache, oral/genital ulceration, erythema, skin pustules, arthralgia, nausea/vomiting/abdominal pain, and diarrhea with altered/frank blood per rectum. Moderate agreement was observed for eye and nervous system involvement. We achieved a fair agreement for arthritis and major vessel involvement. Significant correlations were obtained between the total BDCAF score with the BDQOL and the patient's/clinician's perception of disease activity (p < 0.05). Conclusions: The Korean version of the BDCAF is a reliable and valid instrument for measuring current disease activity in Korean BD patients.

Keywords

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-1291. https://doi.org/10.1056/NEJM199910213411707
  2. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J 2007;48:573-585. https://doi.org/10.3349/ymj.2007.48.4.573
  3. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behcet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 1999;38:728-733. https://doi.org/10.1093/rheumatology/38.8.728
  4. Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's disease activity index. Rheumatology (Oxford) 2004;43:73-78. https://doi.org/10.1093/rheumatology/keg453
  5. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-1080.
  6. Chang HK, Kim SY. Survey and validation of the criteria for Behcet's disease recently used in Korea: a suggestion for modification of the International Study Group criteria. J Korean Med Sci 2003;18:88-92. https://doi.org/10.3346/jkms.2003.18.1.88
  7. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-3191. https://doi.org/10.1097/00007632-200012150-00014
  8. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432. https://doi.org/10.1016/0895-4356(93)90142-N
  9. Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behcet's disease. J Rheumatol 2004;31:931-937.
  10. Touma Z, Ghandour L, Sibai A, et al. Cross-cultural adaptation and validation of Behcet's disease quality of life questionnaire. BMC Med Res Methodol 2011;11:52. https://doi.org/10.1186/1471-2288-11-52
  11. Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES. The Behcet's Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J 2008;49:698-704. https://doi.org/10.3349/ymj.2008.49.5.698
  12. Hamuryudan V, Fresko I, Direskeneli H, et al. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome. Rheumatology (Oxford) 1999;38:734-736. https://doi.org/10.1093/rheumatology/38.8.734
  13. Neves FS, Moraes JC, Kowalski SC, Goldenstein-Sc hainberg C, Lage LV, Goncalves CR. Cross-cultural adaptation of the Behcet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 2007;26:1263-1267. https://doi.org/10.1007/s10067-006-0484-y

Cited by

  1. Validation and reliability of a Behcet’s Syndrome Activity Scale in Korea vol.31, pp.1, 2015, https://doi.org/10.3904/kjim.2016.31.1.170
  2. Behçet's Disease Current Activity Form as a Patient's Derived Measure vol.23, pp.1, 2016, https://doi.org/10.4078/jrd.2016.23.1.19
  3. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet’s disease vol.7, pp.None, 2017, https://doi.org/10.1038/s41598-017-15189-9
  4. Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes vol.10, pp.None, 2015, https://doi.org/10.2147/prom.s163601
  5. Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.769785
  6. Integrative Medicine (Herbal Medicine Combined with Drug Therapy) for Behcet’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials vol.13, pp.4, 2015, https://doi.org/10.3390/pharmaceutics13040476